10
Total investments
1
Early stage
1
Mid stage
0
Late stage
21y
Years active
Portfolio
2 investments · sorted by recency
All investments
Early stage
Mid stage
Late stage
Board Member
Jan 2023
ProteomEdge™ is a company from Stockholm, Sweden, with a mission to bring precision into MS-based absolute quantification of blood plasma proteins. Our proprietary analysis platform offers cleavable heavy-isotope labeled protein standards for targets of both clinical and research interests that is versatile and easy to use. The technology ensures state-of-the-art accuracy in absolute protein quantification using mass spectrometry within a unique format that allows for addition-only protocols and straightforward handling in fully automated pipelines. Our products offer various protein panels for multiplexed analysis of human blood plasma proteins delivered in prealiquoted 96-well plates. This elegant setup outlines a new strategy for unbiased discoveries and confident results.
ApoEdge - Multiplex panel for absolute quantification of all Apolipoproteins
https://proteomedge.com/ae1801/
Board Member
Jan 2013
SciLifeLab is a Swedish national center for molecular biosciences with focus on health and environmental research. The center combines frontline technical expertise with advanced knowledge of translational medicine and molecular bioscience.
SciLifeLab was established in 2010 and appointed a national center in 2013 by the Swedish government. Four additional sites - Lund, Gothenburg, Linköping and Umeå - were appointed in 2021 in addition to the original two sites in Stockholm and Uppsala.
Experience · 10 entries
All (10)
Investments (10)
Board (10)
2025
Board Member
Jul 2025
SSF är en oberoende forskningsfinansiär. Vi finansierar forskning inom naturvetenskap, teknik och medicin som stärker Sveriges konkurrenskraft med många 100 miljoner kronor per år.
2023
Board Member
Jul 2023
The International Society for Molecular Recognition (ISMR) was founded in 1985 and conceived to foster communication between researchers concerned with molecular recognition in chemistry, biology, biotechnology and medicine.
Board Member
Jan 2023
ProteomEdge™ is a company from Stockholm, Sweden, with a mission to bring precision into MS-based absolute quantification of blood plasma proteins. Our proprietary analysis platform offers cleavable heavy-isotope labeled protein standards for targets of both clinical and research interests that is versatile and easy to use. The technology ensures state-of-the-art accuracy in absolute protein quantification using mass spectrometry within a unique format that allows for addition-only protocols and straightforward handling in fully automated pipelines. Our products offer various protein panels for multiplexed analysis of human blood plasma proteins delivered in prealiquoted 96-well plates. This elegant setup outlines a new strategy for unbiased discoveries and confident results.
ApoEdge - Multiplex panel for absolute quantification of all Apolipoproteins
https://proteomedge.com/ae1801/
2020
Board Member
May 2020
Karolinska Institutet is one of the world´s leading medical universities. Our mission is to contribute to the improvement of human health through research and education.
Karolinska Institutet accounts for over 40 per cent of the medical academic research conducted in Sweden and offers the country´s broadest range of education in medicine and health sciences.
Since 1901 the Nobel Assembly at Karolinska Institutet has selected the Nobel laureates in Physiology or Medicine.
Karolinska Institutet was founded by King Karl XIII in 1810 as an "academy for the training of skilled army surgeons". Today, Karolinska Institutet is a modern medical university and one of the foremost in the world.
With our close relationship to the clinical milieu, a well established infrastructure and a stable financial situation, Karolinska Institutet has excellent prerequisites for sustaining high quality research and education.
2017
Board Member
May 2017
Manufacturer and provider of over 22,000 highly validated primary antibodies extensively covering the human proteome". We're a company founded by researchers from the Human Protein Atlas project.
Show all 10 entries ↓
Investment activity
2005–2025 · 10 investments
Recent (last 2 years)Earlier
